Everand Logo

Welcome to Everand!

  • STAT

    STAT+: Pharmalittle: India regulator finds 5% of drug samples are substandard; EMA claims new clinical trial registry is fixed

    by Ed Silverman Jan 19, 2023 1 minute
    Source: Alex Hogan/STAT

    Hello, everyone, and how are you today? A steely gray sky is hovering this morning over the Pharmalot campus, where the official

    You’re reading a preview, subscribe to read more.

    More from STAT

    STAT1 min read
    Opinion: Saving Rural Psychiatry Services Will Require Higher Medicaid Payments
    Unless Medicaid raises its payments to rural psychiatrists, mental health clinics across the heartland will disappear, and with it the mental health care for the patients they serve.
    STAT1 min read
    STAT+: Gene Therapies For Deafness Dredge Up An Old Question: Do Deaf People Want A ‘Cure’?
    As scientists celebrate gene therapy's ability to enable hearing, deaf people are feeling a familiar dread: Are we endangered?
    STAT1 min read
    Opinion: STAT+: Unmasking The ‘Centricity’ Illusion In Clinical Trials
    The glacial pace of change in mechanistic but essential areas of clinical trials undermines the biopharma industry's claims of progress and compassion.

    Related Books & Audiobooks